Keykavous Parang - Publications

Affiliations: 
2000-2013 Biomedical and Pharmaceutical Sciences University of Rhode Island, Providence, RI, United States 
 2013- Medicinal Chemistry and Pharmacology Chapman University, Orange, CA, United States 
Area:
Pharmaceutical Chemistry, Pharmacology
Website:
https://www.chapman.edu/our-faculty/keykavous-parang

177 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Park SE, Sajid MI, Parang K, Tiwari RK. Cyclic Cell-Penetrating Peptides As Efficient Intracellular Drug Delivery Tools. Molecular Pharmaceutics. PMID 31329448 DOI: 10.1021/acs.molpharmaceut.9b00633  0.48
2019 Park SE, Shamloo K, Kristedja TA, Darwish S, Bisoffi M, Parang K, Tiwari RK. EDB-FN Targeted Peptide-Drug Conjugates for Use against Prostate Cancer. International Journal of Molecular Sciences. 20. PMID 31277465 DOI: 10.3390/ijms20133291  0.48
2019 El-Sayed NS, Shirazi AN, Sajid MI, Park SE, Parang K, Tiwari RK. Synthesis and Antiproliferative Activities of Conjugates of Paclitaxel and Camptothecin with a Cyclic Cell-Penetrating Peptide. Molecules (Basel, Switzerland). 24. PMID 30978971 DOI: 10.3390/molecules24071427  0.48
2018 David AA, Park SE, Parang K, Tiwari RK. Antibiotics-Peptide Conjugates Against Multidrug-Resistant Bacterial Pathogens. Current Topics in Medicinal Chemistry. PMID 30499392 DOI: 10.2174/1568026619666181129141524  0.48
2018 Darwish S, Sadeghiani N, Fong S, Mozaffari S, Hamidi P, Withana T, Yang S, Tiwari RK, Parang K. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide. European Journal of Medicinal Chemistry. 161: 594-606. PMID 30396106 DOI: 10.1016/j.ejmech.2018.10.042  0.48
2018 Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents. Molecules (Basel, Switzerland). 23. PMID 30360400 DOI: 10.3390/molecules23102722  0.48
2018 El-Sayed NS, Miyake T, Shirazi AN, Park SE, Clark J, Buchholz S, Parang K, Tiwari R. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters. Molecules (Basel, Switzerland). 23. PMID 29966296 DOI: 10.3390/molecules23071590  0.56
2018 Shirazi AN, Mozaffari S, Sherpa RT, Tiwari R, Parang K. Efficient Intracellular Delivery of Cell-Impermeable Cargo Molecules by Peptides Containing Tryptophan and Histidine. Molecules (Basel, Switzerland). 23. PMID 29949881 DOI: 10.3390/molecules23071536  0.56
2017 Marshall J, Szmydynger-Chodobska J, Rioult-Pedotti MS, Lau K, Chin AT, Kotla SKR, Tiwari RK, Parang K, Threlkeld SW, Chodobski A. TrkB-enhancer facilitates functional recovery after traumatic brain injury. Scientific Reports. 7: 10995. PMID 28887487 DOI: 10.1038/s41598-017-11316-8  0.48
2017 Darwish S, Parang K, Marshall J, Goebel DJ, Tiwari R. Efficient synthesis of CN2097 using in situ activation of sulfhydryl group. Tetrahedron Letters. 58: 3053-3056. PMID 28824209 DOI: 10.1016/j.tetlet.2017.06.066  0.56
2017 Sharma M, El-Sayed NS, Do H, Parang K, Tiwari RK, Aliabadi HM. Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates. Scientific Reports. 7: 6093. PMID 28733622 DOI: 10.1038/s41598-017-06381-y  0.48
2017 Riahifard N, Tavakoli K, Yamaki J, Parang K, Tiwari R. Synthesis and Evaluation of Antimicrobial Activity of [R₄W₄K]-Levofloxacin and [R₄W₄K]-Levofloxacin-Q Conjugates. Molecules (Basel, Switzerland). 22. PMID 28594345 DOI: 10.3390/molecules22060957  0.56
2017 Agarwal HK, Chhikara BS, Doncel GF, Parang K. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 28351588 DOI: 10.1016/j.bmcl.2017.03.031  0.84
2017 Manchanda P, Parshad B, Kumar A, Tiwari RK, Shirazi AN, Parang K, Sharma SK. Design, Synthesis, and Evaluation of the Kinase Inhibition Potential of Pyridylpyrimidinylaminophenyl Derivatives. Archiv Der Pharmazie. PMID 28317151 DOI: 10.1002/ardp.201600390  0.48
2016 Tiwari RK, Brown A, Shirazi AN, Bolton J, Tse A, Verkhivker G, Parang K, Sun G. Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors. Chemmedchem. PMID 27875633 DOI: 10.1002/cmdc.201600387  0.48
2016 Oh D, Darwish SA, Shirazi AN, Tiwari RK, Parang K. Corrigendum: Amphiphilic Bicyclic Peptides as Cellular Delivery Agents. Chemmedchem. 11: 2095. PMID 27647739 DOI: 10.1002/cmdc.201600431  1
2016 Weerakkody D, Moshnikova A, El-Sayed NS, Adochite RC, Slaybaugh G, Golijanin J, Tiwari RK, Andreev OA, Parang K, Reshetnyak YK. Novel pH-Sensitive Cyclic Peptides. Scientific Reports. 6: 31322. PMID 27515582 DOI: 10.1038/srep31322  1
2016 El-Sayed NS, Shirazi AN, El-Meligy MG, El-Ziaty AK, Nagieb ZA, Parang K, Tiwari RK. Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter. International Journal of Biological Macromolecules. 87: 611-22. PMID 26976071 DOI: 10.1016/j.ijbiomac.2016.03.020  1
2016 Banerjee A, Sayeh N, Shirazi AN, Tiwari R, Parang K, Yadav A. Arginine-rich cyclic peptides enhance cellular delivery of anticancer agents: Molecular insights Letters in Drug Design and Discovery. 13: 591-604.  1
2016 Shirazi AN, El-Sayed NS, Tiwari RK, Tavakoli K, Parang K. Cyclic peptide containing hydrophobic and positively charged residues as a drug delivery system for curcumin Current Drug Delivery. 13: 409-417.  1
2015 Beni Y, Dash C, Parang K. Synthesis of β-triphosphotriester pronucleotides. Tetrahedron Letters. 56: 2247-2250. PMID 26661734 DOI: 10.1016/j.tetlet.2015.03.036  1
2015 Shirazi AN, El-Sayed NS, Mandal D, Tiwari RK, Tavakoli K, Etesham M, Parang K. Cysteine and arginine-rich peptides as molecular carriers. Bioorganic & Medicinal Chemistry Letters. PMID 26631317 DOI: 10.1016/j.bmcl.2015.11.052  0.6
2015 Nasrolahi Shirazi A, El-Sayed NS, Tiwari RK, Tavakoli K, Parang K. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin. Current Drug Delivery. PMID 26511089  0.52
2015 Rao VK, Kaswan P, Parang K, Kumar A. Indium triflate catalyzed microwave-assisted alkenylation of methoxyphenols: synthesis of indenes and chromenes. Organic & Biomolecular Chemistry. PMID 26395017 DOI: 10.1039/c5ob01734c  1
2015 Ramos-Molina B, Lick AN, Nasrolahi Shirazi A, Oh D, Tiwari R, El-Sayed NS, Parang K, Lindberg I. Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors. Plos One. 10: e0130417. PMID 26110264 DOI: 10.1371/journal.pone.0130417  1
2015 Marshall J, Wong KY, Rupasinghe CN, Tiwari R, Zhao X, Berberoglu ED, Sinkler C, Liu J, Lee I, Parang K, Spaller MR, Hüttemann M, Goebel DJ. Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential. The Journal of Biological Chemistry. PMID 26100636 DOI: 10.1074/jbc.M115.662791  1
2015 Pemmaraju BP, Malekar S, Agarwal HK, Tiwari RK, Oh D, Doncel GF, Worthen DR, Parang K. Design, synthesis, antiviral activity, and pre-formulation development of poly-L-arginine-fatty acyl derivatives of nucleoside reverse transcriptase inhibitors. Nucleosides, Nucleotides & Nucleic Acids. 34: 1-15. PMID 25513860 DOI: 10.1080/15257770.2014.945649  1
2015 Yoon YK, Ali MA, Wei AC, Choon TS, Shirazi AN, Parang K. Discovery of a potent and highly fluorescent sirtuin inhibitor Medchemcomm. 6: 1857-1863. DOI: 10.1039/c5md00307e  1
2015 Saunthwal RK, Patel M, Tiwari RK, Parang K, Verma AK. On water: Catalyst-free chemoselective synthesis of highly functionalized tetrahydroquinazolines from 2-aminophenylacrylate Green Chemistry. 17: 1434-1441. DOI: 10.1039/c4gc02154a  1
2015 Chand K, Tiwari RK, Kumar S, Shirazi AN, Sharma S, Van Der Eycken EV, Parmar VS, Parang K, Sharma SK. Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives Journal of Heterocyclic Chemistry. 52: 562-572. DOI: 10.1002/jhet.2106  1
2015 Rafinejad A, Fallah-Tafti A, Tiwari R, Shirazi AN, Mandal D, Parang K, Foroumadi A, Akbarzadeh T. Synthesis and evaluation of ethyl 2,4-dioxo-4-arylbutanoate derivatives as Src Kinase inhibitors Journal of Sciences, Islamic Republic of Iran. 26: 321-325.  0.6
2014 Fowler BJ, Gelfand BD, Kim Y, Kerur N, Tarallo V, Hirano Y, Amarnath S, Fowler DH, Radwan M, Young MT, Pittman K, Kubes P, Agarwal HK, Parang K, Hinton DR, et al. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science (New York, N.Y.). 346: 1000-3. PMID 25414314 DOI: 10.1126/science.1261754  1
2014 Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, et al. Antibody landscapes after influenza virus infection or vaccination. Science (New York, N.Y.). 346: 996-1000. PMID 25414313 DOI: 10.1126/science.1256427  1
2014 Nasrolahi Shirazi A, Tiwari RK, Oh D, Sullivan B, Kumar A, Beni YA, Parang K. Cyclic peptide-selenium nanoparticles as drug transporters. Molecular Pharmaceutics. 11: 3631-41. PMID 25184366 DOI: 10.1021/mp500364a  1
2014 Shirazi AN, Paquin KL, Howlett NG, Mandal D, Parang K. Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery Molecules. 19: 13319-13331. PMID 25170952 DOI: 10.3390/molecules190913319  1
2014 Oh D, Sun J, Nasrolahi Shirazi A, LaPlante KL, Rowley DC, Parang K. Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens. Molecular Pharmaceutics. 11: 3528-36. PMID 25157458 DOI: 10.1021/mp5003027  1
2014 Oh D, Darwish SA, Shirazi AN, Tiwari RK, Parang K. Amphiphilic bicyclic peptides as cellular delivery agents. Chemmedchem. 9: 2449-53. PMID 25047914 DOI: 10.1002/cmdc.201402230  1
2014 Almansour AI, Kumar RS, Beevi F, Shirazi AN, Osman H, Ismail R, Choon TS, Sullivan B, McCaffrey K, Nahhas A, Parang K, Ali MA. Facile, regio- and diastereoselective synthesis of spiro-pyrrolidine and pyrrolizine derivatives and evaluation of their antiproliferative activities. Molecules (Basel, Switzerland). 19: 10033-55. PMID 25014532 DOI: 10.3390/molecules190710033  1
2014 Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties. European Journal of Medicinal Chemistry. 83: 448-54. PMID 24992072 DOI: 10.1016/j.ejmech.2014.06.060  1
2014 Oh D, Nasrolahi Shirazi A, Northup K, Sullivan B, Tiwari RK, Bisoffi M, Parang K. Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization. Molecular Pharmaceutics. 11: 2845-54. PMID 24978295 DOI: 10.1021/mp500203e  1
2014 Pemmaraju B, Agarwal HK, Oh D, Buckheit KW, Buckheit RW, Tiwari R, Parang K. Synthesis and Biological Evaluation of 5'-O-Dicarboxylic Fatty Acyl Monoester Derivatives of Anti-HIV Nucleoside Reverse Transcriptase Inhibitors. Tetrahedron Letters. 55: 1983-1986. PMID 24791029 DOI: 10.1016/j.tetlet.2014.02.001  1
2014 Mandal D, Nasrolahi Shirazi A, Parang K. Self-assembly of peptides to nanostructures. Organic & Biomolecular Chemistry. 12: 3544-61. PMID 24756480 DOI: 10.1039/c4ob00447g  0.6
2014 Chand K, Prasad S, Tiwari RK, Shirazi AN, Kumar S, Parang K, Sharma SK. Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives. Bioorganic Chemistry. 53: 75-82. PMID 24632506 DOI: 10.1016/j.bioorg.2014.02.001  1
2014 Ghasemi Pirbalouti A, Sajjadi SE, Parang K. A review (research and patents) on jasmonic acid and its derivatives. Archiv Der Pharmazie. 347: 229-39. PMID 24470216 DOI: 10.1002/ardp.201300287  1
2014 Motavallizadeh S, Fallah-Tafti A, Maleki S, Shirazi AN, Pordeli M, Safavi M, Ardestani SK, Asd S, Tiwari R, Oh D, Shafiee A, Foroumadi A, Parang K, Akbarzadeh T. Synthesis and evaluation of antiproliferative activity of substituted N-(9-oxo-9H-xanthen-4-yl)benzenesulfonamides. Tetrahedron Letters. 55: 373-375. PMID 24453382 DOI: 10.1016/j.tetlet.2013.11.033  1
2014 Yoon YK, Ali MA, Wei AC, Choon TS, Osman H, Parang K, Shirazi AN. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities. Bioorganic & Medicinal Chemistry. 22: 703-10. PMID 24387981 DOI: 10.1016/j.bmc.2013.12.029  1
2014 Verma AK, Patel M, Joshi M, Likhar PR, Tiwari RK, Parang K. Base-mediated chemo- and stereoselective addition of 5-aminoindole/tryptamine and histamines onto alkynes. The Journal of Organic Chemistry. 79: 172-86. PMID 24215621 DOI: 10.1021/jo402352v  1
2014 Chhikara BS, Rao MS, Rao VK, Kumar A, Buckheit KW, Buckheit RW, Parang K. Carbocyclodipeptides as modified nucleosides: Synthesis and anti-HIV activities Canadian Journal of Chemistry. 92: 1145-1149. DOI: 10.1139/cjc-2014-0356  1
2014 Choudhary S, Muthyala MK, Parang K, Kumar A. Ionic liquid-supported sulfonyl hydrazine: A useful reagent for traceless synthesis of pyrazoles Organic Chemistry Frontiers. 1: 683-688. DOI: 10.1039/c4qo00092g  1
2014 Mandal D, Nasrolahi Shirazi A, Parang K. Self-assembly of peptides to nanostructures Organic and Biomolecular Chemistry. 12: 3544-3561. DOI: 10.1039/c4ob00447g  1
2014 El-Sayed NS, Shirazi AN, El-Meligy MG, El-Ziaty AK, Rowley D, Sun J, Nagib ZA, Parang K. Synthesis of 4-aryl-6-indolylpyridine-3-carbonitriles and evaluation of their antiproliferative activity Tetrahedron Letters. 55: 1154-1158. DOI: 10.1016/j.tetlet.2013.12.081  1
2014 Muthyala MK, Velisetti K, Parang K, Kumar A. Advances in functionalized ionic liquids as reagents and scavengers in organic synthesis Current Organic Chemistry. 18: 2530-2554.  1
2014 Sayeh N, Shirazi AN, Oh D, Sun J, Rowley D, Banerjee A, Yadav A, Tiwari RK, Parang K. Amphiphilic triazolyl peptides: Synthesis and evaluation as nanostructures Current Organic Chemistry. 18: 2665-2671.  1
2013 Cao C, Rioult-Pedotti MS, Migani P, Yu CJ, Tiwari R, Parang K, Spaller MR, Goebel DJ, Marshall J. Correction: Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome. Plos Biology. 11. PMID 29364881 DOI: 10.1371/annotation/f32bc670-c9cf-4bb0-9376-cd8cfd1053c1  0.56
2013 Nasrolahi Shirazi A, Oh D, Tiwari RK, Sullivan B, Gupta A, Bothun GD, Parang K. Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters. Molecular Pharmaceutics. 10: 4717-27. PMID 24215132 DOI: 10.1021/mp400539r  1
2013 Mandal D, Tiwari RK, Shirazi AN, Oh D, Ye G, Banerjee A, Yadav A, Parang K. Self-Assembled Surfactant Cyclic Peptide Nanostructures as Stabilizing Agents. Soft Matter. 9. PMID 24187575 DOI: 10.1039/C3SM50764E  1
2013 Rao VK, Tiwari R, Chhikara BS, Shirazi AN, Parang K, Kumar A. Copper triflate-mediated synthesis of 1,3,5-triarylpyrazoles in [bmim][PF6] ionic liquid and evaluation of their anticancer activities. Rsc Advances. 3: 15396-15403. PMID 24163734 DOI: 10.1039/C3RA41830H  1
2013 Suresh N, Nagesh HN, Sekhar KV, Kumar A, Shirazi AN, Parang K. Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 23: 6292-5. PMID 24138941 DOI: 10.1016/j.bmcl.2013.09.077  1
2013 Pericherla K, Shirazi AN, Rao VK, Tiwari RK, DaSilva N, McCaffrey KT, Beni YA, González-Sarrías A, Seeram NP, Parang K, Kumar A. Synthesis and antiproliferative activities of quebecol and its analogs. Bioorganic & Medicinal Chemistry Letters. 23: 5329-31. PMID 23953195 DOI: 10.1016/j.bmcl.2013.07.058  1
2013 Nasrolahi Shirazi A, Tiwari RK, Oh D, Sullivan B, McCaffrey K, Mandal D, Parang K. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters. Molecular Pharmaceutics. 10: 3137-51. PMID 23834324 DOI: 10.1021/mp400199e  1
2013 Nasrolahi Shirazi A, Tiwari RK, Brown A, Mandal D, Sun G, Parang K. Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 3230-4. PMID 23602444 DOI: 10.1016/j.bmcl.2013.03.124  1
2013 Rao VK, Shelke GM, Tiwari R, Parang K, Kumar A. A simple and efficient synthesis of 2,3-diarylnaphthofurans using sequential hydroarylation/Heck oxyarylation. Organic Letters. 15: 2190-3. PMID 23586966 DOI: 10.1021/ol400738r  1
2013 Nasrolahi Shirazi A, Tiwari RK, Oh D, Banerjee A, Yadav A, Parang K. Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine. Molecular Pharmaceutics. 10: 2008-20. PMID 23537165 DOI: 10.1021/mp400046u  1
2013 Cao C, Rioult-Pedotti MS, Migani P, Yu CJ, Tiwari R, Parang K, Spaller MR, Goebel DJ, Marshall J. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. Plos Biology. 11: e1001478. PMID 23424281 DOI: 10.1371/journal.pbio.1001478  1
2013 Nasrolahi Shirazi A, Tiwari R, Chhikara BS, Mandal D, Parang K. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs. Molecular Pharmaceutics. 10: 488-99. PMID 23301519 DOI: 10.1021/mp3004034  1
2013 Nasrolahi Shirazi A, Mandal D, Tiwari RK, Guo L, Lu W, Parang K. Cyclic peptide-capped gold nanoparticles as drug delivery systems. Molecular Pharmaceutics. 10: 500-11. PMID 22998473 DOI: 10.1021/mp300448k  1
2013 Agarwal HK, Chhikara BS, Bhavaraju S, Mandal D, Doncel GF, Parang K. Emtricitabine prodrugs with improved anti-HIV activity and cellular uptake. Molecular Pharmaceutics. 10: 467-76. PMID 22917277 DOI: 10.1021/mp300361a  1
2013 Chand K, Shirazi AN, Yadav P, Tiwari RK, Kumari M, Parang K, Sharma SK. Synthesis and antiproliferative and c-Src kinase inhibitory activities of cinnamoyl-and pyranochromen-2-one derivatives Canadian Journal of Chemistry. 91: 741-754. DOI: 10.1139/cjc-2013-0053  1
2013 Shelke GM, Rao VK, Tiwari RK, Chhikara BS, Parang K, Kumar A. Bismuth triflate-catalyzed condensation of indoles with acetone Rsc Advances. 3: 22346-22352. DOI: 10.1039/c3ra44693j  1
2013 Pericherla K, Kaswan P, Khedar P, Khungar B, Parang K, Kumar A. Copper catalyzed tandem oxidative C-H amination/cyclizations: Direct access to imidazo[1,2-a]pyridines Rsc Advances. 3: 18923-18930. DOI: 10.1039/c3ra43889a  1
2012 Rafinejad A, Fallah-Tafti A, Tiwari R, Shirazi AN, Mandal D, Shafiee A, Parang K, Foroumadi A, Akbarzadeh T. 4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities. Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 20: 100. PMID 23351304 DOI: 10.1186/2008-2231-20-100  1
2012 Chhikara BS, Tiwari R, Parang K. N-Myristoylglutamic Acid Derivative of 3'-Fluoro-3'-Deoxythymidine as an Organogel. Tetrahedron Letters. 53: 5335-5337. PMID 23175585 DOI: 10.1016/j.tetlet.2012.07.101  1
2012 Sharma RK, Singh S, Tiwari R, Mandal D, Olsen CE, Parmar VS, Parang K, Prasad AK. O-Aryl α,β-d-ribofuranosides: synthesis & highly efficient biocatalytic separation of anomers and evaluation of their Src kinase inhibitory activity. Bioorganic & Medicinal Chemistry. 20: 6821-30. PMID 23098606 DOI: 10.1016/j.bmc.2012.09.057  1
2012 Kumar A, Muthyala MK, Choudhary S, Tiwari RK, Parang K. Ionic liquid as soluble support for synthesis of 1,2,3-thiadiazoles and 1,2,3-selenadiazoles. The Journal of Organic Chemistry. 77: 9391-6. PMID 23020655 DOI: 10.1021/jo301607a  1
2012 Agarwal HK, Buckheit KW, Buckheit RW, Parang K. Synthesis and anti-HIV activities of symmetrical dicarboxylate esters of dinucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 5451-4. PMID 22858097 DOI: 10.1016/j.bmcl.2012.07.037  1
2012 Shaik IH, Agarwal HK, Parang K, Mehvar R. Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats. Journal of Pharmaceutical Sciences. 101: 4003-12. PMID 22829462 DOI: 10.1002/jps.23274  1
2012 Tiwari RK, Parang K. Conformationally constrained peptides as protein tyrosine kinase inhibitors. Current Pharmaceutical Design. 18: 2852-66. PMID 22571654  1
2012 Agarwal HK, Chhikara BS, Hanley MJ, Ye G, Doncel GF, Parang K. Synthesis and biological evaluation of fatty acyl ester derivatives of (-)-2',3'-dideoxy-3'-thiacytidine. Journal of Medicinal Chemistry. 55: 4861-71. PMID 22533850 DOI: 10.1021/jm300492q  1
2012 Agarwal HK, Doncel GF, Parang K. Synthesis and anti-HIV activities of suramin conjugates of 3'-fluoro- 2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 8: 193-7. PMID 22385137  1
2012 Agarwal HK, Chhikara BS, Quiterio M, Doncel GF, Parang K. Synthesis and anti-HIV activities of glutamate and peptide conjugates of nucleoside reverse transcriptase inhibitors. Journal of Medicinal Chemistry. 55: 2672-87. PMID 22352809 DOI: 10.1021/jm201551m  1
2012 Chhikara BS, Mandal D, Parang K. Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate. Journal of Medicinal Chemistry. 55: 1500-10. PMID 22276998 DOI: 10.1021/jm201653u  1
2012 Rao VK, Chhikara BS, Tiwari R, Shirazi AN, Parang K, Kumar A. One-pot regioselective synthesis of tetrahydroindazolones and evaluation of their antiproliferative and Src kinase inhibitory activities. Bioorganic & Medicinal Chemistry Letters. 22: 410-4. PMID 22119472 DOI: 10.1016/j.bmcl.2011.10.124  1
2012 Muthayala MK, Chhikara BS, Parang K, Kumar A. Ionic liquid-supported synthesis of sulfonamides and carboxamides. Acs Combinatorial Science. 14: 60-5. PMID 22013985 DOI: 10.1021/co200149m  1
2012 Muthyala MK, Chhikara BS, Parang K, Kumar A. Ionic-liquid-supported 1,5,7-triazabicyclo[4.4.0]dec-5-ene - An efficient and recyclable organocatalyst for Michael addition to α,β-unsaturated ketones Canadian Journal of Chemistry. 90: 290-297. DOI: 10.1139/v11-162  1
2012 Bhandari R, Saiardi A, Ahmadibeni Y, Snowman AM, Resnick AC, Kristiansen TZ, Molina H, Pandey A, Werner JK, Juluri KR, Xu Y, Prestwich GD, Parang K, Snyder SH. Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 39, (15305-15310) DOI: 10.1073/pnas. 0707338104) Proceedings of the National Academy of Sciences of the United States of America. 109: 21171-21173. DOI: 10.1073/pnas.1218152109  1
2012 Rao MS, Chhikara BS, Tiwari R, Shirazi AN, Parang K, Kumar A. Microwave-assisted and scandium triflate catalyzed synthesis of tetrahydrobenzo[a]xanthen-11-ones Monatshefte Fur Chemie. 143: 263-268. DOI: 10.1007/s00706-011-0577-4  1
2011 Ahmadibeni Y, Tiwari R, Swepson C, Pandhare J, Dash C, Doncel GF, Parang K. Synthesis and anti-HIV activities of bis-(cycloSaligenyl) pronucleotides derivatives of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Tetrahedron Letters. 52: 802-805. PMID 26661937 DOI: 10.1016/j.tetlet.2010.12.038  1
2011 Mandal D, Nasrolahi Shirazi A, Parang K. Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters. Angewandte Chemie (International Ed. in English). 50: 9633-7. PMID 21919161 DOI: 10.1002/anie.201102572  1
2011 Fallah-Tafti A, Foroumadi A, Tiwari R, Shirazi AN, Hangauer DG, Bu Y, Akbarzadeh T, Parang K, Shafiee A. Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. European Journal of Medicinal Chemistry. 46: 4853-8. PMID 21852023 DOI: 10.1016/j.ejmech.2011.07.050  1
2011 Fallah-Tafti A, Tiwari R, Shirazi AN, Akbarzadeh T, Mandal D, Shafiee A, Parang K, Foroumadi A. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 7: 466-72. PMID 21801146 DOI: 10.2174/157340611796799258  1
2011 Rao VK, Chhikara BS, Shirazi AN, Tiwari R, Parang K, Kumar A. 3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities. Bioorganic & Medicinal Chemistry Letters. 21: 3511-4. PMID 21612925 DOI: 10.1016/j.bmcl.2011.05.010  1
2011 Dash C, Ahmadibeni Y, Hanley MJ, Pandhare J, Gotte M, Le Grice SF, Parang K. Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside β-triphosphates. Bioorganic & Medicinal Chemistry Letters. 21: 3519-22. PMID 21605974 DOI: 10.1016/j.bmcl.2011.05.005  1
2011 Chhikara BS, St Jean N, Mandal D, Kumar A, Parang K. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities. European Journal of Medicinal Chemistry. 46: 2037-42. PMID 21420207 DOI: 10.1016/j.ejmech.2011.02.056  1
2011 Gupta A, Mandal D, Ahmadibeni Y, Parang K, Bothun G. Hydrophobicity drives the cellular uptake of short cationic peptide ligands. European Biophysics Journal : Ebj. 40: 727-36. PMID 21409455 DOI: 10.1007/s00249-011-0685-4  1
2011 Agarwal HK, Loethan K, Mandal D, Doncel GF, Parang K. Synthesis and biological evaluation of fatty acyl ester derivatives of 2',3'-didehydro-2',3'-dideoxythymidine. Bioorganic & Medicinal Chemistry Letters. 21: 1917-21. PMID 21382714 DOI: 10.1016/j.bmcl.2011.02.070  1
2011 Kumar A, Ahmad I, Chhikara BS, Tiwari R, Mandal D, Parang K. Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities. Bioorganic & Medicinal Chemistry Letters. 21: 1342-6. PMID 21300544 DOI: 10.1016/j.bmcl.2011.01.047  1
2011 Kumar D, Reddy VB, Kumar A, Mandal D, Tiwari R, Parang K. Click chemistry inspired one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles and their Src kinase inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 21: 449-52. PMID 21084189 DOI: 10.1016/j.bmcl.2010.10.121  1
2010 Agarwal HK, Kumar A, Doncel GF, Parang K. Synthesis, antiviral and contraceptive activities of nucleoside-sodium cellulose sulfate acetate and succinate conjugates. Bioorganic & Medicinal Chemistry Letters. 20: 6993-7. PMID 20965725 DOI: 10.1016/j.bmcl.2010.09.133  1
2010 Chhikara BS, Parang K. Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opinion On Drug Delivery. 7: 1399-414. PMID 20964588 DOI: 10.1517/17425247.2010.527330  1
2010 Chhikara BS, Mandal D, Parang K. Synthesis and evaluation of fatty acyl ester derivatives of cytarabine as anti-leukemia agents. European Journal of Medicinal Chemistry. 45: 4601-8. PMID 20692740 DOI: 10.1016/j.ejmech.2010.07.024  1
2010 Ahmadibeni Y, Dash C, Le Grice SF, Parang K. Solid-Phase Synthesis of 5'-O-β,γ-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase. Tetrahedron Letters. 51: 3010-3013. PMID 20454539 DOI: 10.1016/j.tetlet.2010.04.005  1
2010 Sharma D, Sharma RK, Bhatia S, Tiwari R, Mandal D, Lehmann J, Parang K, Olsen CE, Parmar VS, Prasad AK. Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols. Biochimie. 92: 1164-72. PMID 20447438 DOI: 10.1016/j.biochi.2010.04.022  1
2010 Ahmadibeni Y, Dash C, Hanley MJ, Le Grice SF, Agarwal HK, Parang K. Synthesis of nucleoside 5'-O-alpha,beta-methylene-beta-triphosphates and evaluation of their potency towards inhibition of HIV-1 reverse transcriptase. Organic & Biomolecular Chemistry. 8: 1271-4. PMID 20204192 DOI: 10.1039/b922846b  1
2010 Tiwari R, Brown A, Narramaneni S, Sun G, Parang K. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands. Biochimie. 92: 1153-63. PMID 20109515 DOI: 10.1016/j.biochi.2010.01.017  1
2010 Ye G, Gupta A, DeLuca R, Parang K, Bothun GD. Bilayer disruption and liposome restructuring by a homologous series of small Arg-rich synthetic peptides. Colloids and Surfaces. B, Biointerfaces. 76: 76-81. PMID 19913394 DOI: 10.1016/j.colsurfb.2009.10.016  1
2010 Penugonda S, Agarwal HK, Parang K, Mehvar R. Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats. Journal of Pharmaceutical Sciences. 99: 1626-37. PMID 19780131 DOI: 10.1002/jps.21934  1
2009 Carballeira NM, Miranda C, Parang K. The first total synthesis of (±)-4-methoxydecanoic acid: a novel antifungal fatty acid. Tetrahedron Letters. 50: 5699-5700. PMID 20161109 DOI: 10.1016/j.tetlet.2009.07.074  1
2009 Tiwari R, Parang K. Protein conjugates of SH3-domain ligands and ATP-competitive inhibitors as bivalent inhibitors of protein kinases. Chembiochem : a European Journal of Chemical Biology. 10: 2445-8. PMID 19731277 DOI: 10.1002/cbic.200900462  1
2009 Ye G, Schuler AD, Ahmadibeni Y, Morgan JR, Faruqui A, Huang K, Sun G, Zebala JA, Parang K. Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain. Bioorganic Chemistry. 37: 133-42. PMID 19539345 DOI: 10.1016/j.bioorg.2009.05.003  1
2009 Ahmadibeni Y, Tiwari RK, Sun G, Parang K. Synthesis of nucleoside mono-, di-, and triphosphoramidates from solid-phase cyclosaligenyl phosphitylating reagents. Organic Letters. 11: 2157-60. PMID 19364114 DOI: 10.1021/ol900320r  1
2009 Ahmadibeni Y, Parang K. Solid-supported reagents for synthesis of nucleoside monothiophosphates, dithiodiphosphates, and trithiotriphosphates. Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit13.9. PMID 19319857 DOI: 10.1002/0471142700.nc1309s36  1
2008 Ahmadibeni Y, Parang K. Solid-supported diphosphitylating and triphosphitylating reagents for nucleoside modification. Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit 13.8. PMID 18551427 DOI: 10.1002/0471142700.nc1308s33  1
2008 Ye G, Tiwari R, Parang K. Development of Src tyrosine kinase substrate binding site inhibitors. Current Opinion in Investigational Drugs (London, England : 2000). 9: 605-13. PMID 18516760  1
2008 Penugonda S, Kumar A, Agarwal HK, Parang K, Mehvar R. Synthesis and in vitro characterization of novel dextran-methylprednisolone conjugates with peptide linkers: effects of linker length on hydrolytic and enzymatic release of methylprednisolone and its peptidyl intermediates. Journal of Pharmaceutical Sciences. 97: 2649-64. PMID 17853426 DOI: 10.1002/jps.21161  1
2008 Agarwal HK, Doncel GF, Parang K. Synthesis and anti-HIV activities of phosphate triester derivatives of 3′-fluoro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine Tetrahedron Letters. 49: 4905-4907. DOI: 10.1016/j.tetlet.2008.05.149  1
2008 Gupta A, Bothun GD, Deluca R, Ye G, Parang K. Interaction mechanisms between a homologous series of tripodal cationic peptides and lipid bilayer membranes Aiche Annual Meeting, Conference Proceedings 1
2007 Chimalakonda KC, Agarwal HK, Kumar A, Parang K, Mehvar R. Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine-dextran conjugate for selective antiviral delivery to the liver. Bioconjugate Chemistry. 18: 2097-108. PMID 17922546 DOI: 10.1021/bc700193d  1
2007 Ahmadibeni Y, Parang K. Solid-phase synthesis of symmetrical 5',5'-dinucleoside mono-, di-, tri-, and tetraphosphodiesters. Organic Letters. 9: 4483-6. PMID 17915884 DOI: 10.1021/ol7018778  1
2007 Bhandari R, Saiardi A, Ahmadibeni Y, Snowman AM, Resnick AC, Kristiansen TZ, Molina H, Pandey A, Werner JK, Juluri KR, Xu Y, Prestwich GD, Parang K, Snyder SH. Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event. Proceedings of the National Academy of Sciences of the United States of America. 104: 15305-10. PMID 17873058 DOI: 10.1073/pnas.0707338104  1
2007 Ahmadibeni Y, Hanley M, White M, Ayrapetov M, Lin X, Sun G, Parang K. Metal-binding properties of a dicysteine-containing motif in protein tyrosine kinases. Chembiochem : a European Journal of Chemical Biology. 8: 1592-605. PMID 17674392 DOI: 10.1002/cbic.200700242  1
2007 Carballeira NM, O'Neill R, Parang K. Synthesis and antifungal properties of alpha-methoxy and alpha-hydroxyl substituted 4-thiatetradecanoic acids. Chemistry and Physics of Lipids. 150: 82-8. PMID 17662704 DOI: 10.1016/j.chemphyslip.2007.06.218  1
2007 Ye G, Nam NH, Kumar A, Saleh A, Shenoy DB, Amiji MM, Lin X, Sun G, Parang K. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides. Journal of Medicinal Chemistry. 50: 3604-17. PMID 17580848 DOI: 10.1021/jm070416o  1
2007 Kumar A, Wang Y, Lin X, Sun G, Parang K. Synthesis and evaluation of 3-phenylpyrazolo[3,4-d]pyrimidine-peptide conjugates as Src kinase inhibitors. Chemmedchem. 2: 1346-60. PMID 17530729 DOI: 10.1002/cmdc.200700074  1
2007 Ahmadibeni Y, Parang K. Synthesis and evaluation of modified oligodeoxynucleotides containing diphosphodiester internucleotide linkages. Angewandte Chemie (International Ed. in English). 46: 4739-43. PMID 17497623 DOI: 10.1002/anie.200605029  1
2007 Agarwal HK, Parang K. Application of solid-phase chemistry for the synthesis of 3'-fluoro-3'-deoxythymidine. Nucleosides, Nucleotides & Nucleic Acids. 26: 317-22. PMID 17454740 DOI: 10.1080/15257770701257608  1
2006 Gu X, Wang Y, Kumar A, Ye G, Parang K, Sun G. Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase. Journal of Medicinal Chemistry. 49: 7532-9. PMID 17149882 DOI: 10.1021/jm061058c  1
2006 Kumar A, Ye G, Ahmadibeni Y, Parang K. Synthesis of polymer-bound 4-acetoxy-3-phenylbenzaldehyde derivatives: applications in solid-phase organic synthesis. The Journal of Organic Chemistry. 71: 7915-8. PMID 16995713 DOI: 10.1021/jo061328z  1
2006 Carballeira NM, Sanabria D, Cruz C, Parang K, Wan B, Franzblau S. 2,6-hexadecadiynoic acid and 2,6-nonadecadiynoic acid: novel synthesized acetylenic fatty acids as potent antifungal agents. Lipids. 41: 507-11. PMID 16933795 DOI: 10.1007/s11745-006-5124-4  1
2006 Ahmadibeni Y, Parang K. Solid-phase synthesis of dinucleoside and nucleoside-carbohydrate phosphodiesters and thiophosphodiesters. The Journal of Organic Chemistry. 71: 6693-6. PMID 16901175 DOI: 10.1021/jo0611115  1
2006 Ahmadibeni Y, Parang K. Application of a solid-phase beta-triphosphitylating reagent in the synthesis of nucleoside beta-triphosphates. The Journal of Organic Chemistry. 71: 5837-9. PMID 16839180 DOI: 10.1021/jo0610107  1
2006 Ayrapetov MK, Wang YH, Lin X, Gu X, Parang K, Sun G. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation. The Journal of Biological Chemistry. 281: 23776-84. PMID 16790421 DOI: 10.1074/jbc.M604219200  1
2006 Kumar A, Ye G, Wang Y, Lin X, Sun G, Parang K. Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 49: 3395-401. PMID 16722659 DOI: 10.1021/jm060334k  1
2006 Lin X, Wang Y, Ahmadibeni Y, Parang K, Sun G. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase. Journal of Molecular Biology. 357: 1263-73. PMID 16483606 DOI: 10.1016/j.jmb.2006.01.046  1
2006 Lee S, Ayrapetov MK, Kemble DJ, Parang K, Sun G. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk). The Journal of Biological Chemistry. 281: 8183-9. PMID 16439366 DOI: 10.1074/jbc.M508120200  1
2005 Ahmadibeni Y, Parang K. Selective diphosphorylation, dithiodiphosphorylation, triphosphorylation, and trithiotriphosphorylation of unprotected carbohydrates and nucleosides. Organic Letters. 7: 5589-92. PMID 16320998 DOI: 10.1021/ol0521432  1
2005 Ye G, Ayrapetov M, Nam NH, Sun G, Parang K. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 15: 4994-7. PMID 16169725 DOI: 10.1016/j.bmcl.2005.08.005  1
2005 Carballeira NM, Sanabria D, Parang K. Total synthesis and further scrutiny of the in vitro antifungal activity of 6-nonadecynoic acid. Archiv Der Pharmazie. 338: 441-3. PMID 16143955 DOI: 10.1002/ardp.200500102  1
2005 Hines AC, Parang K, Kohanski RA, Hubbard SR, Cole PA. Bisubstrate analog probes for the insulin receptor protein tyrosine kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design. Bioorganic Chemistry. 33: 285-97. PMID 16023488 DOI: 10.1016/j.bioorg.2005.02.002  1
2005 Carballeira NM, O'Neill R, Parang K. Racemic and optically active 2-methoxy-4-oxatetradecanoic acids: novel synthetic fatty acids with selective antifungal properties. Chemistry and Physics of Lipids. 136: 47-54. PMID 15899476 DOI: 10.1016/j.chemphyslip.2005.03.002  1
2005 Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. The Journal of Biological Chemistry. 280: 25780-7. PMID 15890649 DOI: 10.1074/jbc.M504022200  1
2005 Ahmadibeni Y, Parang K. Polymer-bound oxathiaphospholane: a solid-phase reagent for regioselective monothiophosphorylation and monophosphorylation of unprotected nucleosides and carbohydrates. Organic Letters. 7: 1955-8. PMID 15876028 DOI: 10.1021/ol050385w  1
2005 Lin X, Ayrapetov MK, Lee S, Parang K, Sun G. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk. Biochemistry. 44: 1561-7. PMID 15683240 DOI: 10.1021/bi048142j  1
2005 Ahmadibeni Y, Parang K. Solid-phase reagents for selective monophosphorylation of carbohydrates and nucleosides. The Journal of Organic Chemistry. 70: 1100-3. PMID 15675883 DOI: 10.1021/jo048113e  1
2005 Parang K. Editorial Current Pharmaceutical Design. 11: 3729. DOI: 10.2174/138161205774580660  1
2005 Parang K, Sun G. Recent advances in the discovery of Src kinase inhibitors Expert Opinion On Therapeutic Patents. 15: 1183-1207. DOI: 10.1517/13543776.15.9.1183  1
2005 Parang K, Sun G. Protein Kinase Inhibitors Drug Discovery Drug Discovery Handbook. 1191-1257. DOI: 10.1002/0471728780.ch26  1
2004 Nam NH, Sardari S, Selecky M, Parang K. Carboxylic acid and phosphate ester derivatives of fluconazole: synthesis and antifungal activities. Bioorganic & Medicinal Chemistry. 12: 6255-69. PMID 15519168 DOI: 10.1016/j.bmc.2004.08.049  1
2004 Parang K, Sun G. Design strategies for protein kinase inhibitors. Current Opinion in Drug Discovery & Development. 7: 617-29. PMID 15503864  1
2004 Nam NH, Lee S, Ye G, Sun G, Parang K. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases. Bioorganic & Medicinal Chemistry. 12: 5753-66. PMID 15498652 DOI: 10.1016/j.bmc.2004.08.043  1
2004 Schmidt B, Jiricek J, Titz A, Ye G, Parang K. Copper dipicolinates as peptidomimetic ligands for the Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 14: 4203-6. PMID 15261270 DOI: 10.1016/j.bmcl.2004.06.018  1
2004 Nam NH, Ye G, Sun G, Parang K. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. Journal of Medicinal Chemistry. 47: 3131-41. PMID 15163193 DOI: 10.1021/jm040008+  1
2004 Carballeira NM, Ortiz D, Parang K, Sardari S. Total synthesis and in vitro-antifungal activity of (+/-)-2-methoxytetradecanoic Acid. Archiv Der Pharmazie. 337: 152-5. PMID 15038060 DOI: 10.1002/ardp.200300824  1
2004 Force T, Kuida K, Namchuk M, Parang K, Kyriakis JM. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease. Circulation. 109: 1196-205. PMID 15023894 DOI: 10.1161/01.CIR.0000118538.21306.A9  1
2004 Nam NH, Pitts RL, Sun G, Sardari S, Tiemo A, Xie M, Yan B, Parang K. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain. Bioorganic & Medicinal Chemistry. 12: 779-87. PMID 14759738 DOI: 10.1016/j.bmc.2003.10.060  1
2003 Lee S, Lin X, Nam NH, Parang K, Sun G. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase. Proceedings of the National Academy of Sciences of the United States of America. 100: 14707-12. PMID 14657361 DOI: 10.1073/pnas.2534493100  1
2003 Nam NH, Sardari S, Parang K. Reactions of solid-supported reagents and solid supports with alcohols and phenols through their hydroxyl functional group. Journal of Combinatorial Chemistry. 5: 479-546. PMID 12959554 DOI: 10.1021/cc020106l  1
2003 Nam NH, Parang K. Current targets for anticancer drug discovery. Current Drug Targets. 4: 159-79. PMID 12558068 DOI: 10.2174/1389450033346966  1
2003 Sardari S, Pourmorad F, Tiemo A, Nam NH, Parang K. Protein Kinases and their Modulation in the Central Nervous System Current Medicinal Chemistry - Central Nervous System Agents. 3: 341-364. DOI: 10.2174/1568015033477677  1
2003 Parang K. Preface Current Pharmaceutical Design. 9.  1
2002 Parang K, Cole PA. Designing bisubstrate analog inhibitors for protein kinases. Pharmacology & Therapeutics. 93: 145-57. PMID 12191607 DOI: 10.1016/S0163-7258(02)00184-5  1
2002 Parang K. Polymer-supported reagents for methylphosphorylation and phosphorylation of carbohydrates. Bioorganic & Medicinal Chemistry Letters. 12: 1863-6. PMID 12086835 DOI: 10.1016/S0960-894X(02)00266-4  1
2002 Parang K, Kohn JA, Saldanha SA, Cole PA. Development of photo-crosslinking reagents for protein kinase-substrate interactions. Febs Letters. 520: 156-60. PMID 12044889 DOI: 10.1016/S0014-5793(02)02778-3  1
2001 Parang K, Fournier EJ, Hindsgaul O. A solid phase reagent for the capture phosphorylation of carbohydrates and nucleosides. Organic Letters. 3: 307-9. PMID 11430061 DOI: 10.1021/ol0069498  1
2001 Parang K, Till JH, Ablooglu AJ, Kohanski RA, Hubbard SR, Cole PA. Mechanism-based design of a protein kinase inhibitor. Nature Structural Biology. 8: 37-41. PMID 11135668 DOI: 10.1038/83028  1
2000 Parang K, Wiebe LI, Knaus EE. Novel approaches for designing 5'-O-ester prodrugs of 3'-Azido-2',3'-dideoxythymidine (AZT) Current Medicinal Chemistry. 7: 995-1039. PMID 10911016  1
2000 Kim K, Parang K, Lau OD, Cole PA. Tyrosine analogues as alternative substrates for protein tyrosine kinase Csk: Insights into substrate selectivity and catalytic mechanism Bioorganic and Medicinal Chemistry. 8: 1263-1268. PMID 10896106 DOI: 10.1016/S0968-0896(00)00053-5  1
2000 Ablooglu AJ, Till JH, Kim K, Parang K, Cole PA, Hubbard SR, Kohanski RA. Probing the catalytic mechanism of the insulin receptor kinase with a tetrafluorotyrosine-containing peptide substrate. The Journal of Biological Chemistry. 275: 30394-8. PMID 10869355 DOI: 10.1074/jbc.M003524200  1
1998 Parang K, Wiebe LI, Knaus EE, Huang JS, Tyrrell DL. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT). Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 1: 108-14. PMID 10948398  1
1998 Parang K, Wiebe LI, Knaus EE. Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5'-O-myristoyl analogue derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) as potential prodrugs Antiviral Chemistry and Chemotherapy. 9: 311-323. PMID 9875410  1
1998 Parang K, Wiebe LI, Knaus EE. Pharmacokinetics and tissue distribution of (±)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice Journal of Pharmacy and Pharmacology. 50: 989-996. PMID 9811159  1
1998 Parang K, Knaus EE, Wiebe LI. Synthesis, in vitro anti-HIV activity, and biological stability of 5'- O-myristoyl analogue derivatives of 3'-fluoro-2',3'dideoxythymidine (FLT) as potential bifunctional prodrugs of FLT Nucleosides and Nucleotides. 17: 987-1008. PMID 9708320  1
1997 Parang K, Wiebe LI, Knaus EE, Huang JS, Tyrrell DL, Csizmadia F. In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses Antiviral Research. 34: 75-90. PMID 9191015 DOI: 10.1016/S0166-3542(96)01022-4  1
1997 Parang K, Wiebe LI, Knaus EE. Syntheses and biological evaluation of 5'-O-myristoyl derivatives of thymidine against human immunodeficiency virus Antiviral Chemistry and Chemotherapy. 8: 417-427.  1
1996 Parang K, Knaus EE, Wiebe LI, Sardari S, Daneshtalab M, Csizmadia F. Synthesis and antifungal activities of myristic acid analogs Archiv Der Pharmazie. 329: 475-482. PMID 8997896  1
1994 Sharifian A, Parang K, Zorrieh-Amirian H, Nazarinia M, Shafiee A. Syntheses of 1-substituted 1,2,4-triazoles, imidazoles and benzimidazoles Journal of Heterocyclic Chemistry. 31: 1421-1423.  1
1992 Shafiee A, Parang K, Khazan M, Ghasemian F. Nitroimidazoles X . Syntheses of substituted 2‐(1‐methyl‐5‐nitro‐2‐imidazolyl)quinolines Journal of Heterocyclic Chemistry. 29: 1859-1861. DOI: 10.1002/jhet.5570290732  1
1992 Shafiee A, Pirouzzadeh B, Ghasemian F, Parang K. Nitroimidazoles. IX. Synthesis of 2‐acetyl‐1‐methyl‐5‐nitroimidazole Journal of Heterocyclic Chemistry. 29: 1021-1023. DOI: 10.1002/jhet.5570290461  1
Show low-probability matches.